Novo Nordisk A/S ADR buy BiotechBee
Start price
07.09.22
/
70%
€104.00
Target price
31.12.25
€180.00
Performance (%)
41.35%
End price
05.05.23
€147.00
Summary
This prediction ended on 05.05.23 with a price of €147.00. With a performance of 41.35% the BUY prediction by BiotechBee was a big success. A total of €1.10 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 1.360% | 1.360% | -53.142% | -74.774% |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % | 52,00 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % | 95,66 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % | 52,99 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % | 66,53 % |
According to BiotechBee what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Buy mit Kursziel 180,0